The best indicator for NiSource (NI)
We backtested 366 indicators across daily, weekly and hourly charts on real NiSource (NI) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
SMA 20/50 Cross
On the weekly chart, this is the strongest risk-adjusted edge we found for NiSource (NI) over ~53.5 years — beating buy-and-hold by 0.4% CAGR.
Best multi-indicator combo
Going long only when all 2 agree was the strongest confluence setup we found for NiSource (NI) — trailing buy-and-hold by 4.3% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | SMA 20/50 Cross ✓ | Weekly | 8.4% | 0.61 | -34.2% | 68.2% | 22 | 0.4% |
| 2 | TRIX (21) ✓ | Weekly | 8.5% | 0.6 | -32.6% | 81.2% | 16 | 0.5% |
| 3 | KAMA 10/30 Cross ✓ | Weekly | 8.3% | 0.59 | -46.6% | 65.7% | 35 | 0.3% |
| 4 | SMA 20/80 Cross ✓ | Weekly | 8.4% | 0.58 | -36.7% | 60.0% | 15 | 0.4% |
| 5 | TRIX (15) ✓ | Weekly | 8.2% | 0.58 | -43.7% | 58.3% | 24 | 0.2% |
| 6 | EMA 20/50 Cross ✓ | Weekly | 7.9% | 0.57 | -44.2% | 68.8% | 16 | -0.1% |
| 7 | Ichimoku TK Cross ✓ | Weekly | 7.6% | 0.56 | -68.9% | 48.2% | 56 | -0.4% |
| 8 | MA Ribbon ✓ | Weekly | 6.8% | 0.56 | -43.3% | 55.8% | 43 | -1.2% |
| 9 | EMA 15/60 Cross ✓ | Weekly | 7.8% | 0.56 | -46.1% | 64.7% | 17 | -0.2% |
| 10 | T3 10/40 Cross ✓ | Weekly | 7.4% | 0.56 | -42.4% | 64.0% | 25 | -0.6% |
| 11 | T3 15/60 Cross ✓ | Weekly | 8.1% | 0.6 | -36.7% | 64.3% | 14 | 0.1% |
| 12 | TRIMA 200 Trend ✓ | Daily | 6.9% | 0.55 | -58.1% | 39.1% | 115 | -1.1% |
| 13 | Supertrend (14,4) ✓ | Weekly | 7.4% | 0.55 | -48.5% | 52.9% | 17 | -0.6% |
| 14 | SMA 15/60 Cross ✓ | Weekly | 7.6% | 0.55 | -41.0% | 59.1% | 22 | -0.4% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For NiSource (NI), SMA 20/50 Cross on the weekly timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.